HOME >> MEDICINE >> NEWS
Greater cooperation needed for advancement of stem cell research

Nashville, Tenn. - December 13, 2006 -- Tissue regeneration strategies, such as stem cell research, have undergone notable developments over the past two decades. However, an article in the journal, Artificial Organs, suggests that many challenges must be overcome before regenerative medicine is accepted as a viable science.

Though the past decade has seen significant achievements in certain applications of regenerative medicine, it remains primarily a laboratory science with few successful products to attest to its promise. Despite widespread efforts for commercialization, the field failed to keep pace with the publics expectations. "This brought about the perception that this was not a viable clinical alternative to organ transplantation," says Dr. V. Prasad Shastri, author of the study.

Stem cell-based therapy and other tissue regeneration strategies have the potential to revolutionize regenerative medicine and disease treatment. However, the challenges associated with this research, including limited access to stem cells and other materials, in addition to the fact that research is currently funded by the private sector, remain obstacles.

There is currently a lack of a coherent, comprehensive and unified government policy towards cutting edge research involving stem cells. Poor support from the government is further inhibited by geo-political considerations and there is inadequate public information on the research and a near complete absence of public debate.

In order to reverse the perception of regenerative medicine as non-functional, clear goals with tangible benefits must be set. All parties involved in this research must cooperate in order to ensure outcomes that are consistent with promises.

"With the proper framework and participation of all sectors of society and political support, tissue regenerative technologies are poised to change clinical medicine and significantly enhance the quality of lif
'"/>

Contact: Sean Wagner
swagner@bos.blackwellpublishing.com
781-388-8550
Blackwell Publishing Ltd.
13-Dec-2006


Page: 1 2

Related medicine news :

1. Greater use of evidence-based medicine needed in US outpatient care
2. Greater risk of death for cardiac surgery patients with long ICU stay
3. International cooperation boosts EarthCARE
4. BMJ highlights lack of international cooperation to investigate scientific fraud
5. Steps needed to reduce smoking in the US
6. New treatments needed for irritable bowel syndrome
7. Animal BiP levels determine amount of recovery sleep needed following prolonged wakefulness
8. More research needed to involve families in psychosocial interventions
9. New health insurance survey -- Women have trouble affording care needed
10. Teens get needed access to care with state health insurance
11. General physicals prompt needed cancer screenings

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has ... least understood books in the Holy Scriptures, Revelation. The Book of Revelation paints a ... centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins says that ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the ... danger possible to save lost souls in the Philippines. “The Journey: From the Mountains ... a dedicated teacher of the Bible. She has taught all ages and currently teaches ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 ... characterized by frequent cessation in breathing. Oral appliances can offer significant relief to ...
(Date:10/12/2017)... CITY, Fla. (PRWEB) , ... October 12, 2017 , ... ... cold therapy products, announced today the introduction of an innovative new design of the ... multipurpose pad so you get maximum comfort while controlling your pain while using cold ...
(Date:10/12/2017)... ... 2017 , ... Information about the technology: , Otomagnetics has ... prevention of a major side effect of chemotherapy in children. Cisplatin and carboplatin ... cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. Hearing ...
Breaking Medicine News(10 mins):
(Date:10/10/2017)... received FDA 510(k) clearance in May 2017 for its highly anticipated ... for endoscopy environments. An innovative secondary monitor solution, ZeroWire Mobile ... the improvement of patient outcomes, procedural efficiency, and the lowering of ... ... By ...
(Date:10/4/2017)...  South Korean-based healthcare product Development Company I.M. Lab ... Kickstarter. The device will educate the user about ,proper, ... efficiency compared to the dated and pricey CPR training ... of the compression for a more informed CPR training. ... raise $5,000. cprCUBE ...
(Date:10/2/2017)... 2017  Eli Lilly and Company (NYSE: ... third quarter of 2017 on Tuesday, October 24, 2017. ... day with the investment community and media to further ... call will begin at 9 a.m. Eastern time. Investors, ... webcast of the conference call through a link that ...
Breaking Medicine Technology:
Cached News: